Translation initiation in eukaryotic cells is crucial for gene regulation during stress, development, and disease. Recent studies have elucidated the molecular mechanisms of the translation initiation machinery, including the roles of eukaryotic initiation factors (eIFs) and the scanning mechanism that identifies the start codon. In eukaryotes, the 40S ribosomal subunit scans the 5' untranslated region (5'UTR) for an AUG codon, while in bacteria, the Shine-Dalgarno sequence pairs with the 16S rRNA to recruit the ribosome. The eIF4F complex, consisting of eIF4E, eIF4G, and eIF4A, activates mRNAs by recognizing the 5' cap structure. The scanning process is regulated by eIF1 and eIF1A, which stabilize the mRNA binding cleft and promote or inhibit scanning. The multifactor complex (MFC) enhances PIC assembly, and eIF3 plays a key role in recruiting the 43S PIC to the mRNA. The 43S PIC binds to the mRNA, scans for the start codon, and initiates translation. The 60S subunit joins to form the 80S initiation complex, and eIF5B catalyzes subunit joining. The eIF2B complex, which is inhibited by eIF2α phosphorylation, regulates general translation. The eIF2α kinase GCN2 is activated by amino acid starvation and phosphorylates eIF2α, leading to reduced translation and increased translation of specific mRNAs. The eIF4E-binding protein (4E-BP) inhibits cap-dependent translation by competing with eIF4G for binding to eIF4E. The mTOR signaling pathway regulates 4E-BP and S6K phosphorylation, which control translation. miRNAs regulate translation by binding to the 3'UTR of mRNAs and inhibiting protein expression. Translational control is also important in the nervous system, where it regulates synaptic plasticity and memory. In development, sequence-specific RNA-binding proteins repress translation of specific mRNAs. In disease, dysregulation of translation factors contributes to cancer and metabolic disorders. The balance between cap-dependent and IRES-dependent translation is critical for tumorigenesis. Translational control plays a role in metabolic diseases, such as obesity, and in neuropsychiatric disorders like fragile X syndrome. Viruses exploit the host's translation machinery to synthesize their proteins and counteract host defenses.Translation initiation in eukaryotic cells is crucial for gene regulation during stress, development, and disease. Recent studies have elucidated the molecular mechanisms of the translation initiation machinery, including the roles of eukaryotic initiation factors (eIFs) and the scanning mechanism that identifies the start codon. In eukaryotes, the 40S ribosomal subunit scans the 5' untranslated region (5'UTR) for an AUG codon, while in bacteria, the Shine-Dalgarno sequence pairs with the 16S rRNA to recruit the ribosome. The eIF4F complex, consisting of eIF4E, eIF4G, and eIF4A, activates mRNAs by recognizing the 5' cap structure. The scanning process is regulated by eIF1 and eIF1A, which stabilize the mRNA binding cleft and promote or inhibit scanning. The multifactor complex (MFC) enhances PIC assembly, and eIF3 plays a key role in recruiting the 43S PIC to the mRNA. The 43S PIC binds to the mRNA, scans for the start codon, and initiates translation. The 60S subunit joins to form the 80S initiation complex, and eIF5B catalyzes subunit joining. The eIF2B complex, which is inhibited by eIF2α phosphorylation, regulates general translation. The eIF2α kinase GCN2 is activated by amino acid starvation and phosphorylates eIF2α, leading to reduced translation and increased translation of specific mRNAs. The eIF4E-binding protein (4E-BP) inhibits cap-dependent translation by competing with eIF4G for binding to eIF4E. The mTOR signaling pathway regulates 4E-BP and S6K phosphorylation, which control translation. miRNAs regulate translation by binding to the 3'UTR of mRNAs and inhibiting protein expression. Translational control is also important in the nervous system, where it regulates synaptic plasticity and memory. In development, sequence-specific RNA-binding proteins repress translation of specific mRNAs. In disease, dysregulation of translation factors contributes to cancer and metabolic disorders. The balance between cap-dependent and IRES-dependent translation is critical for tumorigenesis. Translational control plays a role in metabolic diseases, such as obesity, and in neuropsychiatric disorders like fragile X syndrome. Viruses exploit the host's translation machinery to synthesize their proteins and counteract host defenses.